Clinical trial
Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
NCT01918527 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
- Lead sponsor
- Vejle Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- June 30, 2026
- Enrollment
- 250 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer